Cargando…
Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy
BACKGROUND: Desmopressin increases plasma factor VIII and von Willebrand factor levels in persons with nonsevere hemophilia A. Patients’ perspectives on desmopressin are relevant to increase and optimize its suboptimal use. However, patients’ views on desmopressin are not reported. OBJECTIVES: To ev...
Autores principales: | Romano, Lorenzo G.R., van Vulpen, Lize F.D., den Exter, Paul L., Heubel-Moenen, Floor C.J.I., Hooijmeijer, Helene L., Coppens, Michiel, Fijnvandraat, Karin, Schols, Saskia E.M., Ypma, Paula F., Smit, Cees, Driessens, Mariëtte H.E., Rosendaal, Frits R., van der Bom, Johanna G., Gouw, Samantha C., Kruip, Marieke J.H.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439392/ https://www.ncbi.nlm.nih.gov/pubmed/37601028 http://dx.doi.org/10.1016/j.rpth.2023.100281 |
Ejemplares similares
-
Joint status of patients with nonsevere hemophilia A
por: Zwagemaker, Anne‐Fleur, et al.
Publicado: (2022) -
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
por: Goedhart, Tine M.H.J., et al.
Publicado: (2022) -
The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022) -
Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019
por: Hassan, Shermarke, et al.
Publicado: (2021) -
Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting
por: Zwagemaker, Anne‐Fleur, et al.
Publicado: (2022)